Yin Hang, Duffy Diane M, Gosden Roger G
The Jones Institute for Reproductive Medicine, Department of Obstetrics and Gynaecology Eastern Virginia Medical School, Norfolk, VA 23507, USA.
Reprod Biol Endocrinol. 2006 Apr 4;4:14. doi: 10.1186/1477-7827-4-14.
In vitro maturation (IVM) of oocytes followed by fertilization in vitro (IVF) and embryo transfer offers an alternative to conventional IVF treatment that minimises drug administration and avoids ovarian hyperstimulation. However, the technique is less efficient than maturation in vivo. In the present study, a non-human primate model was used to address the hypothesis that the number of oocytes is increased and their nuclear and cytoplasmic maturity after IVM are improved when maturation is initiated in vivo by priming with hCG.
Young, adult cynomolgus monkeys were given recombinant human (rh) gonadotropins to stimulate the development of multiple follicles, and oocytes were aspirated 0, 12, 24, or 36 h after injection of an ovulatory dose of rhCG. The nuclear status of oocytes was determined at the time of recovery and after culture for a total elapsed time of 40-44 hours after hCG.
Priming with hCG significantly increased the number of oocytes harvested, especially after delaying aspiration for 24 h or longer. Nuclear maturation after the full period in culture was also enhanced by priming: 71.5, 83.6, and 94.6% of oocytes collected at 0, 12, and 24 h hCG had progressed to MII by the end of the culture period, compared to 87.8% of oocytes that were retrieved at 36 h. A large proportion of oocytes reaching the MII stage had either or both abnormal spindles (>40%) and misaligned chromosomes (>60%), judging by immunofluorescence microscopy, but these abnormalities were independent of culture time. The mitochondria were evenly distributed throughout the cytoplasm at all stages of maturation. Importantly, there was no microscopic evidence that the duration of culture had any injurious effects on the cells.
In conclusion, the evidence supports this non-human primate as a model for human IVM and the practice of priming with hCG to promote developmental potential.
卵母细胞体外成熟(IVM)后进行体外受精(IVF)和胚胎移植,为传统IVF治疗提供了一种替代方法,可将药物使用降至最低并避免卵巢过度刺激。然而,该技术的效率低于体内成熟。在本研究中,使用非人类灵长类动物模型来验证以下假设:通过hCG预处理在体内启动成熟时,卵母细胞数量会增加,且IVM后其核成熟和胞质成熟会得到改善。
给年轻的成年食蟹猴注射重组人(rh)促性腺激素以刺激多个卵泡发育,在注射排卵剂量的rhCG后0、12、24或36小时抽吸卵母细胞。在回收时以及hCG后总共培养40 - 44小时后确定卵母细胞的核状态。
hCG预处理显著增加了收获的卵母细胞数量,尤其是在延迟抽吸24小时或更长时间后。预处理还增强了培养全期后的核成熟:在hCG后0、12和24小时收集的卵母细胞中,分别有71.5%、83.6%和94.6%在培养期结束时进展到MII期,而在36小时回收的卵母细胞中这一比例为87.8%。通过免疫荧光显微镜判断,达到MII期的大部分卵母细胞存在异常纺锤体(>40%)和染色体排列异常(>60%)中的一种或两种情况,但这些异常与培养时间无关。在成熟的各个阶段,线粒体均匀分布于整个细胞质中。重要的是,没有微观证据表明培养时间对细胞有任何有害影响。
总之,证据支持将这种非人类灵长类动物作为人类IVM的模型以及使用hCG预处理来促进发育潜能的做法。